4.6 Review

NMDA receptors in axons: there's no coincidence

Journal

JOURNAL OF PHYSIOLOGY-LONDON
Volume 599, Issue 2, Pages 367-387

Publisher

WILEY
DOI: 10.1113/JP280059

Keywords

axon; long-term plasticity; metabotropic signalling; neuropathic pain; neurotransmitter release; NMDA receptor; presynaptic terminal; short-term plasticity

Funding

  1. CFI [LOF 28331]
  2. CIHR [OG 126137, NIA 288936]
  3. FRQS [CB 254033]
  4. NSERC [DG 418546-2, DG 2017-04730, DAS 2017-507818]
  5. HBHL Postdoctoral Fellowship
  6. FRQS Postdoctoral Fellowship [259572]
  7. HBHL Graduate Student Fellowship
  8. RI-MUHC Studentship
  9. Marie Sklodowska-Curie Individual Fellowship [892837]
  10. Marie Curie Actions (MSCA) [892837] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

Axonally located preNMDARs have been reported in the literature for decades, with recent discoveries showing their key involvement in different brain regions and forms of plasticity, highlighting the role of unusual subunit composition. These preNMDARs can signal through both ionotropic action and metabotropic mode, explaining the controversy surrounding this receptor type.
In the textbook view, N-methyl-d-aspartate (NMDA) receptors are postsynaptically located detectors of coincident activity in Hebbian learning. However, controversial presynaptically located NMDA receptors (preNMDARs) have for decades been repeatedly reported in the literature. These preNMDARs have typically been implicated in the regulation of short-term and long-term plasticity, but precisely how they signal and what their functional roles are have been poorly understood. The functional roles of preNMDARs across several brain regions and different forms of plasticity can differ vastly, with recent discoveries showing key involvement of unusual subunit composition. Increasing evidence shows preNMDAR can signal through both ionotropic action by fluxing calcium and in metabotropic mode even in the presence of magnesium blockade. We argue that these unusual properties may explain why controversy has surrounded this receptor type. In addition, the expression of preNMDARs at some synapse types but not others can underlie synapse-type-specific plasticity. Last but not least, preNMDARs are emerging therapeutic targets in disease states such as neuropathic pain. We conclude that axonally located preNMDARs are required for specific purposes and do not end up there by accident.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available